Kinnate Biopharma shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Kinnate Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Kinnate Biopharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kinnate Biopharma by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $370k | 156k | 2.37 |
| 2023-09-30 | $111k | 79k | 1.40 |
| 2023-06-30 | $482k | 159k | 3.03 |
| 2023-03-31 | $1.4M | 220k | 6.25 |
| 2022-12-31 | $439k | 72k | 6.10 |
| 2022-06-30 | $2.7M | 211k | 12.61 |
| 2022-03-31 | $767k | 68k | 11.25 |
| 2021-12-31 | $1.0M | 57k | 17.73 |
| 2021-09-30 | $2.2M | 95k | 23.02 |
| 2021-03-31 | $554k | 18k | 31.17 |
| 2020-12-31 | $2.4M | 60k | 39.78 |